(•‿-) ChemoCentryx +80% - Announces FDA Approval of TAVNEOS™ (avacopan) in ANCA-Associated asculitis - https://ir.chemocentryx.com/news-releases/news-release-details/chemocentryx-announces-fda-approval-tavneostm-avacopan-anca $CCXI $IFRX NEXT!!!
(•‿-) ChemoCentryx +80% - Announces FDA Approval of TAVNEOS™ (avacopan) in ANCA-Associated asculitis - https://ir.chemocentryx.com/news-releases/news-release-details/chemocentryx-announces-fda-approval-tavneostm-avacopan-anca $CCXI $IFRX NEXT!!!